vs
IRIDEX CORP（IRIX）与FiscalNote Holdings, Inc.（NOTE）财务数据对比。点击上方公司名可切换其他公司
FiscalNote Holdings, Inc.的季度营收约是IRIDEX CORP的1.5倍（$22.2M vs $14.7M），FiscalNote Holdings, Inc.同比增速更快（-24.7% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs -16.8%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
FiscalNote Holdings, Inc.（常称FiscalNote）是一家上市的软件数据与传媒企业，总部位于美国华盛顿特区，2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯，同时依托人工智能平台分析美国待审议法案相关内容。
IRIX vs NOTE — 直观对比
营收规模更大
NOTE
是对方的1.5倍
$14.7M
营收增速更快
NOTE
高出45.1%
-69.7%
两年增速更快
IRIX
近两年复合增速
-16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $22.2M |
| 净利润 | — | — |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | -83.7% |
| 净利率 | — | — |
| 营收同比 | -69.7% | -24.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $-2.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXNOTE
| Q4 25 | $14.7M | $22.2M | ||
| Q3 25 | $12.5M | $22.4M | ||
| Q2 25 | $13.6M | $23.3M | ||
| Q1 25 | $11.9M | $27.5M | ||
| Q4 24 | $12.7M | $29.5M | ||
| Q3 24 | $11.6M | $29.4M | ||
| Q2 24 | $12.6M | $29.2M | ||
| Q1 24 | $11.8M | $32.1M |
净利润IRIXNOTE
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | $-24.9M | ||
| Q2 25 | $-994.0K | $-13.3M | ||
| Q1 25 | $-1.7M | $-4.3M | ||
| Q4 24 | $-834.0K | — | ||
| Q3 24 | $-1.9M | $-14.9M | ||
| Q2 24 | $-2.7M | $-12.8M | ||
| Q1 24 | $-3.5M | $50.6M |
毛利率IRIXNOTE
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率IRIXNOTE
| Q4 25 | — | -83.7% | ||
| Q3 25 | -11.3% | -43.4% | ||
| Q2 25 | -6.9% | -31.9% | ||
| Q1 25 | -1.7% | -50.0% | ||
| Q4 24 | -3.9% | -19.4% | ||
| Q3 24 | -16.1% | -23.1% | ||
| Q2 24 | -20.9% | -27.2% | ||
| Q1 24 | -28.0% | -35.6% |
净利率IRIXNOTE
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | -110.8% | ||
| Q2 25 | -7.3% | -57.0% | ||
| Q1 25 | -14.2% | -15.4% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -16.7% | -50.7% | ||
| Q2 24 | -21.2% | -43.6% | ||
| Q1 24 | -29.5% | 157.6% |
每股收益（稀释后）IRIXNOTE
| Q4 25 | — | $-2.81 | ||
| Q3 25 | $-0.09 | $-1.73 | ||
| Q2 25 | $-0.06 | $-0.08 | ||
| Q1 25 | $-0.10 | $-0.03 | ||
| Q4 24 | $-0.05 | $1.88 | ||
| Q3 24 | $-0.12 | $-1.33 | ||
| Q2 24 | $-0.16 | $-0.09 | ||
| Q1 24 | $-0.21 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $26.3M |
| 总债务越低越好 | — | $128.4M |
| 股东权益账面价值 | — | $62.0M |
| 总资产 | $29.2M | $255.1M |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资IRIXNOTE
| Q4 25 | $6.0M | $26.3M | ||
| Q3 25 | $5.6M | $31.2M | ||
| Q2 25 | $6.8M | $38.5M | ||
| Q1 25 | $7.2M | $46.3M | ||
| Q4 24 | $2.4M | $34.6M | ||
| Q3 24 | $3.9M | $32.7M | ||
| Q2 24 | $4.1M | $37.7M | ||
| Q1 24 | $5.4M | $43.6M |
总债务IRIXNOTE
| Q4 25 | — | $128.4M | ||
| Q3 25 | — | $131.5M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $118.0M | ||
| Q4 24 | $1.0M | $147.1M | ||
| Q3 24 | $1.4M | $152.2M | ||
| Q2 24 | — | $145.9M | ||
| Q1 24 | — | $153.0M |
股东权益IRIXNOTE
| Q4 25 | — | $62.0M | ||
| Q3 25 | $4.7M | $75.5M | ||
| Q2 25 | $6.1M | $95.1M | ||
| Q1 25 | $852.0K | $98.7M | ||
| Q4 24 | $2.1M | $97.8M | ||
| Q3 24 | $2.6M | $98.5M | ||
| Q2 24 | $4.2M | $106.9M | ||
| Q1 24 | $6.5M | $106.1M |
总资产IRIXNOTE
| Q4 25 | $29.2M | $255.1M | ||
| Q3 25 | $28.4M | $273.9M | ||
| Q2 25 | $31.6M | $288.3M | ||
| Q1 25 | $34.2M | $299.7M | ||
| Q4 24 | $29.1M | $326.2M | ||
| Q3 24 | $30.2M | $337.9M | ||
| Q2 24 | $31.2M | $346.3M | ||
| Q1 24 | $34.1M | $357.8M |
负债/权益比IRIXNOTE
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | 0.48× | 1.50× | ||
| Q3 24 | 0.53× | 1.54× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-279.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.9M |
| 自由现金流率自由现金流/营收 | — | -8.7% |
| 资本支出强度资本支出/营收 | — | 7.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-18.6M |
8季度趋势，按日历期对齐
经营现金流IRIXNOTE
| Q4 25 | — | $-279.0K | ||
| Q3 25 | $-1.2M | $-8.3M | ||
| Q2 25 | $-397.0K | $-6.2M | ||
| Q1 25 | $-1.1M | $3.3M | ||
| Q4 24 | $-1.2M | $-1.3M | ||
| Q3 24 | $-3.1M | $-3.0M | ||
| Q2 24 | $-1.3M | $-3.7M | ||
| Q1 24 | $-1.6M | $2.7M |
自由现金流IRIXNOTE
| Q4 25 | — | $-1.9M | ||
| Q3 25 | $-1.2M | $-10.4M | ||
| Q2 25 | $-410.0K | $-7.7M | ||
| Q1 25 | $-1.2M | $1.3M | ||
| Q4 24 | $-1.2M | $-3.4M | ||
| Q3 24 | $-3.1M | $-5.4M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | $-1.7M | $1.0M |
自由现金流率IRIXNOTE
| Q4 25 | — | -8.7% | ||
| Q3 25 | -9.4% | -46.2% | ||
| Q2 25 | -3.0% | -33.0% | ||
| Q1 25 | -9.8% | 4.7% | ||
| Q4 24 | -9.8% | -11.4% | ||
| Q3 24 | -26.5% | -18.4% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | -14.0% | 3.3% |
资本支出强度IRIXNOTE
| Q4 25 | — | 7.4% | ||
| Q3 25 | 0.1% | 9.3% | ||
| Q2 25 | 0.1% | 6.4% | ||
| Q1 25 | 0.1% | 7.2% | ||
| Q4 24 | 0.1% | 6.8% | ||
| Q3 24 | 0.0% | 8.3% | ||
| Q2 24 | 0.0% | 9.4% | ||
| Q1 24 | 0.0% | 5.3% |
现金转化率IRIXNOTE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRIX
暂无分部数据
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |
